Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
|
Medicamen Biotech
|
Zim Laboratories
|
Albert David
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.49 % | 7.41 % | 11.47 % |
|
5yr average Equity Multiplier
|
1.47 | 1.88 | 1.63 |
|
5yr Average Asset Turnover Ratio
|
0.58 | 0.94 | 0.62 |
|
5yr Avg Net Profit Margin
|
10.0 % | 4.15 % | 11.31 % |
|
Price to Book
|
2.45 | 2.09 | 1.27 |
|
P/E
|
73.38 | 43.2 | 79.21 |
|
5yr Avg Cash Conversion Cycle
|
13.14 Days | 37.07 Days | -77.77 Days |
|
Inventory Days
|
66.66 Days | 68.72 Days | 47.91 Days |
|
Days Receivable
|
122.66 Days | 99.71 Days | 27.87 Days |
|
Days Payable
|
257.34 Days | 143.26 Days | 140.35 Days |
|
5yr Average Interest Coverage Ratio
|
10.36 | 3.96 | 93.73 |
|
5yr Avg ROCE
|
12.12 % | 13.52 % | 14.69 % |
|
5yr Avg Operating Profit Margin
|
16.84 % | 12.21 % | 9.55 % |
|
5 yr average Debt to Equity
|
0.14 | 0.39 | 0.02 |
|
5yr CAGR Net Profit
|
-6.51 % | 10.7 % | -4.92 % |
|
5yr Average Return on Assets
|
5.75 % | 4.02 % | 7.03 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.46 % | 33.26 % | 62.24 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.14 % | 0.0 | 0.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medicamen Biotech
|
Zim Laboratories
|
Albert David
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|